FDA now investigating second Johnson & Johnson plant in Pennsylvania
The U.S. Food & Drug Administration is investigating a Johnson & Johnson plant in Lancaster, Pennsylvania, just months after FDA scrutiny led J&J to shut down a plant in Fort Washington, Pennsylvania. The FDA found poor maintenance, record-keeping, and quality control at the Lancaster plant.
The Fort Washington plant had previously recalled infant gas-relief drops due to possible metal shavings and other products due to bacterial contamination.
The Lancaster plant is jointly owned by J&J and Merck.
About the author:
Catherine Bertram is board certified in civil trials and was recently nominated as a 2010 Super Lawyer for personal injury law in Washington, D.C. Ms. Bertram has 20 years of trial experience and is unique in that she was formerly the Director of Risk Management in Washington, D.C. Ms. Bertram is a member of the bar for the U.S. Supreme Court. She is a partner with the firm and lectures regularly to lawyers, nationally and locally, regarding trial strategy, complex medical issues and other related consumer safety issues. She has also recently published a chapter in a surgical textbook. She can be reached by email at cbertram@reganfirm.com or by phone 202-822-1875 in her office in Washington, D.C.
